| Dr George Marshall Gibbins, MD | |
|
1029 Christine Ave, Anniston, AL 36207-5709 | |
| (256) 237-0371 | |
| (256) 236-4181 |
| Full Name | Dr George Marshall Gibbins |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1029 Christine Ave, Anniston, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861591596 | NPI | - | NPPES |
| 000002270 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 00005414 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Marshall Gibbins, MD 1029 Christine Ave, Anniston, AL 36207-5709 Ph: (256) 237-0371 | Dr George Marshall Gibbins, MD 1029 Christine Ave, Anniston, AL 36207-5709 Ph: (256) 237-0371 |
News Archive
"Although polls have consistently shown that just over half of Americans think the health-care system is in need of reform, a substantial majority say they are satisfied with their own insurance and care," the Washington Post reports.
Blue Cross and Blue Shield of Minnesota and its family of companies (Blue Cross) today announced audited financial results for 2010. The nonprofit health company reported full-year 2010 revenues of $9 billion and an operating margin of 1.4%, which resulted in a net operating income of $127 million. This marks the second consecutive year of positive operating results, following three consecutive years of operating losses from 2006 to 2008.
Two studies in today's Nature Neuroscience, led by researchers at Boston Children's Hospital, Brigham and Women's Hospital (BWH), and Harvard Medical School (HMS), implicate mosaic mutations arising during embryonic development as a cause of autism spectrum disorder (ASD). The findings open new areas for exploring the genetics of ASD and could eventually inform diagnostic testing.
Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.
› Verified 1 days ago
David Sidney Lewis, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1029 Christine Ave, Anniston, AL 36207 Phone: 256-237-0371 Fax: 256-236-4181 | |
Kent Calhoun Keys, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1029 Christine Ave, Anniston, AL 36207 Phone: 256-237-0371 Fax: 256-236-4181 | |
Abdul Ahad Kazi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 822 Leighton Ave, Anniston, AL 36207 Phone: 256-237-6769 Fax: 256-237-6719 |